Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients

标题
Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients
作者
关键词
Adalimumab, Anti-TNF-α, Etanercept, Metabolic syndrome, Methotrexate, Psoriatic arthritis
出版物
CLINICAL RHEUMATOLOGY
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2013-08-19
DOI
10.1007/s10067-013-2369-1

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started